[Preliminary studies on immunosuppressive therapy of connective tissue disorders]

Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centers.

Bone marrow transplantation·2013

Myeloma cells suppress osteoblasts through sclerostin secretion.

Blood cancer journal·2012

Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia.

Oncogene·2010

Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients.

Leukemia·2009

Subsets of CD34+ and early engraftment kinetics in allogeneic peripheral SCT for AML.

Bone marrow transplantation·2008

Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience.

Annals of hematology·2007

Genetic thrombophilia in cancer-associated thrombosis: the fly plowing with the ox or an old player's new role?

Haematologica·2026

From prognostic discrimination to clinical utility in high-risk myeloma. Comment on: "Risk factors and their contributions to prognosis in multiple myeloma".

Haematologica·2026

Learning from relapse: how MajesTEC-1 immune profiling points the way to next-generation bispecific strategies.

Haematologica·2026

Making remissions last: the promise of maintenance in primary central nervous system lymphoma.

Haematologica·2026

Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratification.

Haematologica·2026

The many faces (and phenotypes) of BCR::ABL1-driven acute leukemia.

Haematologica·2026

Impact of immunotherapy in the treatment of early-stage non-small lung cancer, melanoma, and colorectal cancer.

Immunotherapy·2026

Biochemical, radiological and histological effects of ixekizumab on skin tissue in a bleomycin-induced systemic sclerosis mouse model.

Clinical and experimental rheumatology·2026

A Multicentre Experience of Inner-Branched Endovascular Aneurysm Repair for Treatment of Type Ia Endoleak After EVAR.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2026

Injection-based safety of aqueous venom immunotherapy during venom extract shortage: impact of forced depot-to-aqueous switching.

Immunotherapy·2026

Intrathecal Ropivacaine Versus Levobupivacaine for Infraumbilical Surgery: A Randomized Double-Blind Trial.

Cureus·2026

Bypassing the bypass: complex laparoscopic reparation of internal hernia after laparotomic Roux-en-Y gastric bypass.

Journal of surgical case reports·2026

Related Experiment Videos

[Preliminary studies on immunosuppressive therapy of connective tissue disorders]

Related Concept Videos

Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centers.

Myeloma cells suppress osteoblasts through sclerostin secretion.

Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia.

Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients.

Subsets of CD34+ and early engraftment kinetics in allogeneic peripheral SCT for AML.

Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience.

Genetic thrombophilia in cancer-associated thrombosis: the fly plowing with the ox or an old player's new role?

From prognostic discrimination to clinical utility in high-risk myeloma. Comment on: "Risk factors and their contributions to prognosis in multiple myeloma".

Learning from relapse: how MajesTEC-1 immune profiling points the way to next-generation bispecific strategies.

Making remissions last: the promise of maintenance in primary central nervous system lymphoma.

Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratification.

The many faces (and phenotypes) of BCR::ABL1-driven acute leukemia.

Impact of immunotherapy in the treatment of early-stage non-small lung cancer, melanoma, and colorectal cancer.

Biochemical, radiological and histological effects of ixekizumab on skin tissue in a bleomycin-induced systemic sclerosis mouse model.

A Multicentre Experience of Inner-Branched Endovascular Aneurysm Repair for Treatment of Type Ia Endoleak After EVAR.

Injection-based safety of aqueous venom immunotherapy during venom extract shortage: impact of forced depot-to-aqueous switching.

Intrathecal Ropivacaine Versus Levobupivacaine for Infraumbilical Surgery: A Randomized Double-Blind Trial.

Bypassing the bypass: complex laparoscopic reparation of internal hernia after laparotomic Roux-en-Y gastric bypass.

Related Experiment Videos

[Preliminary studies on immunosuppressive therapy of connective tissue disorders]

Related Concept Videos

Related Articles